Table 4. The effects associated with sarcopenia traits in the discovery and validation cohorts.
Metabolite | ALM/BMI | HGS | |||||||||||
Discovery cohort | Validation cohort | Discovery cohort | Validation cohort | ||||||||||
Overall | White | Black | Women | Men | overall | White | Black | Women | Men | ||||
Aspartic acid | -0.0217 | -0.0016 | -0.0122 | 0.0251 | -0.0185 | 0.0061 | -1.8126 | -0.2053 | -0.0213 | -0.5099 | -0.1444 | -0.4212 | |
Glutamic acid | -0.0242 | -0.0255 | -0.0219 | -0.0159 | -0.0217 | -0.0171 | -1.0832 | -1.8610 | -2.7074 | -1.4658 | -1.6002 | -2.8643 | |
Glutamine | 0.0055 | 0.0096 | 0.0051 | 0.0242 | 0.0114 | 0.0020 | -0.6150 | 0.0828 | 0.6324 | -0.9101 | -0.3811 | 0.4758 | |
N-Acetyl-L-aspartic acid | 0.0132 | 0.0062 | -0.0006 | 0.0067 | -0.0031 | 0.0035 | 2.2071 | 0.3889 | 0.9694 | -0.1936 | -0.7651 | 0.7507 | |
Serine | -0.0010 | 0.0111 | 0.0066 | 0.0134 | 0.0087 | 0.0083 | 0.1427 | -0.5708 | -0.8434 | 0.0111 | -0.0173 | -0.6966 | |
4-Hydroxyproline | 0.0071 | -0.0040 | 0.0096 | -0.0102 | 0.0239 | -0.0175 | 0.1824 | -0.0942 | 0.0443 | -0.6128 | 0.8805 | -0.8552 | |
Arginine | -0.0053 | -0.0005 | -0.0160 | 0.0163 | -0.0057 | 0.0027 | 0.2956 | -0.1371 | -0.4751 | 0.5423 | -0.1930 | 0.0777 | |
Ornithine | 0.0126 | 0.0037 | -0.0059 | 0.0107 | -0.0012 | 0.0031 | 0.1149 | 0.0960 | -0.1391 | 0.0735 | -0.1766 | 0.3235 | |
Proline | 0.0016 | -0.0110 | -0.0157 | 0.0068 | -0.0171 | -0.0040 | 0.9811 | -0.4799 | -0.0328 | -0.7278 | 0.1212 | -0.8645 | |
Carnosine | -0.0103 | 0.0083 | 0.0117 | 0.0036 | 0.0119 | 0.0026 | 0.0681 | -1.0917 | -1.8010 | -0.7936 | 0.3106 | -1.5213 | |
Histidine | -0.0130 | 0.0056 | -0.0027 | 0.0194 | -0.0080 | 0.0101 | -0.4155 | -0.8430 | -0.6724 | -1.2067 | -0.2238 | -1.3029 | |
Urocanic acid | -0.0006 | 0.0007 | -0.0141 | 0.0199 | -0.0168 | 0.0210 | -0.5849 | -0.1167 | -0.7393 | 1.0734 | -0.5771 | 0.9171 |
All the effects were associated with 1-standard deviation changes in metabolites.
ALM/BMI, body mass index adjusted appendicular lean mass; HGS, hand grip strength.